Orphan designation: Maytansinoid-conjugated human monoclonal antibody against mesothelin (anetumab ravtansine), Treatment of malignant mesothelioma

Case Medical Research ◽

10.31525/cmr-399676 ◽

2018 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Malignant Mesothelioma ◽

Human Monoclonal Antibody ◽

Orphan Designation

Download Full-text

Orphan designation: Anti-neonatal Fc receptor human monoclonal antibody, Prevention of haemolytic disease of the foetus and newborn

Case Medical Research ◽

10.31525/cmr-277ad45 ◽

2020 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Human Monoclonal Antibody ◽

Fc Receptor ◽

Neonatal Fc Receptor ◽

Haemolytic Disease ◽

Orphan Designation

Download Full-text

Orphan designation: human monoclonal antibody against activin A, Treatment of fibrodysplasia ossificans progressiva

Case Medical Research ◽

10.31525/cmr-2629dc2 ◽

2020 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Human Monoclonal Antibody ◽

Activin A ◽

Fibrodysplasia Ossificans Progressiva ◽

Orphan Designation

Download Full-text

Orphan designation: Recombinant human monoclonal antibody to insulin receptor, Treatment of congenital hyperinsulinism

Case Medical Research ◽

10.31525/cmr-ff5e13 ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Insulin Receptor ◽

Human Monoclonal Antibody ◽

Congenital Hyperinsulinism ◽

Orphan Designation

Download Full-text

Orphan designation: Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class (atinumab), Treatment of spinal cord injury

Case Medical Research ◽

10.31525/cmr-1f67607 ◽

2019 ◽

Author(s):

Keyword(s):

Spinal Cord ◽

Monoclonal Antibody ◽

Spinal Cord Injury ◽

Human Monoclonal Antibody ◽

Orphan Designation ◽

Download Full-text

Orphan designation: Recombinant human monoclonal antibody to insulin receptor, Treatment of congenital hyperinsulinism

Case Medical Research ◽

10.31525/cmr-ff52d3 ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Insulin Receptor ◽

Human Monoclonal Antibody ◽

Congenital Hyperinsulinism ◽

Orphan Designation

Download Full-text

Orphan designation: human monoclonal antibody against activin A, Treatment of fibrodysplasia ossificans progressiva

Case Medical Research ◽

10.31525/cmr-2629db8 ◽

2020 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Human Monoclonal Antibody ◽

Activin A ◽

Fibrodysplasia Ossificans Progressiva ◽

Orphan Designation

Download Full-text

Orphan designation: Recombinant human monoclonal antibody against hepatitis-B virus (active ingredient lenvervimab), Prevention of hepatitis-B re-infection following liver transplantation

Case Medical Research ◽

10.31525/cmr-288cebc ◽

2020 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Liver Transplantation ◽

Hepatitis B Virus ◽

Hepatitis B ◽

Active Ingredient ◽

Human Monoclonal Antibody ◽

Orphan Designation ◽

Download Full-text

Orphan designation: Recombinant human monoclonal antibody against activin receptor type IIB, Treatment of inclusion-body myositis

Case Medical Research ◽

10.31525/cmr-3996be ◽

2018 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Inclusion Body ◽

Inclusion Body Myositis ◽

Human Monoclonal Antibody ◽

Receptor Type ◽

Activin Receptor ◽

Orphan Designation

Download Full-text

Human Monoclonal Antibody 216

10.32388/37v9zn ◽

2020 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Human Monoclonal Antibody

Download Full-text

Orphan designation: Humanised IgG4 monoclonal antibody against total complement component 1, subcomponent s, Treatment of autoimmune haemolytic anaemia

Case Medical Research ◽

10.31525/cmr-4e9a86 ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Haemolytic Anaemia ◽

Complement Component ◽

Autoimmune Haemolytic Anaemia ◽

Orphan Designation ◽

Total Complement

Download Full-text